Indication

Enlarged Pores

1 clinical trial

1 product

1 drug

Clinical trial

A Prospective, Randomized, Double-blind, Placebo-controlled, Multi-center Exploratory Study to Investigate NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

Status: Active (not recruiting), Estimated PCD: 2024-06-01

Product

Drug